Insiders · VIGL

VIGL insider transactions

Vigil Neuroscience Inc. (VIGL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

VIGL insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Vigil Neuroscience Inc., latest first. Follow anyone to get their next filing.

• Atlas Venture Fund XII, L.P.10% owner
• Mary ThistleDirector, since April 2022
• Petra KaufmannChief Medical Officer, since March 2024
• Budd Haeberlein Samantha L.Director, since May 2023+$20.5K
• Jennifer Lynn ZiolkowskiChief Financial Officer, Director+$15.1K
• Bruce BoothDirector
• Stefan VitorovicDirector
• Ivana Magovcevic-LiebischPresident and CEO, Director+$61.8K
• Gray David L. F.Chief Science Officer, since February 2023
• Suzanne Louise BruhnDirector, since July 2022
• Cheryl R BlanchardDirector
• Gerhard KoenigDirector
• Christopher VerniGeneral Counsel, since April 2022+$15.1K
• Christopher SilberOfficer, since August 2023
• Spyros PapapetropoulosOfficer+$13.6K-$4,200
• Clay ThorpDirector+$126K
• Evan ThackaberryOfficer+$6,000

Recent Form 3, 4, and 5 filings for VIGL

• 463d
  Large owner Atlas Venture Fund Xii, L.P. returned 5,836,874 shares to the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Director Thistle Mary returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  SEC Form 4 filed by Chief Medical Officer Kaufmann Petra

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Director Budd Haeberlein Samantha L. returned 17,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Chief Financial Officer Ziolkowski Jennifer Lynn returned 4,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Director Booth Bruce returned 5,841,874 shares to the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Director Vitorovic Stefan returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  President and CEO Magovcevic-Liebisch Ivana returned 222,687 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  SEC Form 4 filed by Chief Science Officer Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Director Bruhn Suzanne Louise returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Director Blanchard Cheryl R returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 465d
  Director Koenig Gerhard returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 539d
  Director Booth Bruce was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 539d
  Director Vitorovic Stefan was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 539d
  Director Bruhn Suzanne Louise was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 539d
  Director Koenig Gerhard was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 539d
  Director Budd Haeberlein Samantha L. was granted 5,000 shares, increasing direct ownership by 42% to 17,000 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 539d
  Director Blanchard Cheryl R was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 539d
  Director Thistle Mary was granted 5,000 shares (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 619d
  SEC Form 4 filed by Chief Medical Officer Kaufmann Petra

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 619d
  SEC Form 4 filed by Director Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 619d
  SEC Form 4 filed by Chief Financial Officer Ziolkowski Jennifer Lynn

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 619d
  SEC Form 4 filed by President and CEO Magovcevic-Liebisch Ivana

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 619d
  SEC Form 4 filed by Chief Science Officer Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 619d
  SEC Form 4 filed by Director Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 694d
  Director Budd Haeberlein Samantha L. bought $20,520 worth of shares (12,000 units at $1.71) (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 694d
  President and CEO Magovcevic-Liebisch Ivana bought $8,400 worth of shares (5,000 units at $1.68), increasing direct ownership by 2% to 222,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 695d
  President and CEO Magovcevic-Liebisch Ivana bought $8,350 worth of Common Stock (5,000 units at $1.67), increasing direct ownership by 2% to 217,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 708d
  President and CEO Magovcevic-Liebisch Ivana bought $11,700 worth of shares (5,000 units at $2.34), increasing direct ownership by 2% to 212,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 889d
  SEC Form 4 filed by Vitorovic Stefan

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 889d
  SEC Form 4 filed by Thistle Mary

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 889d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 889d
  SEC Form 4 filed by Blanchard Cheryl R

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 889d
  SEC Form 4 filed by Koenig Gerhard

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 889d
  SEC Form 4 filed by Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 889d
  SEC Form 4 filed by Budd Haeberlein Samantha L.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Vitorovic Stefan

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Verni Christopher

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Thistle Mary

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Blanchard Cheryl R

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Budd Haeberlein Samantha L.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Koenig Gerhard

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Ziolkowski Jennifer Lynn

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 920d
  SEC Form 4 filed by Magovcevic-Liebisch Ivana

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 968d
  SEC Form 4 filed by Kaufmann Petra

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 968d
  SEC Form 3 filed by new insider Kaufmann Petra

  3 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 983d
  SEC Form 4 filed by Booth Bruce

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 983d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 983d
  SEC Form 4 filed by Blanchard Cheryl R

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 987d
  SEC Form 4 filed by Verni Christopher

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 987d
  SEC Form 4 filed by Ziolkowski Jennifer Lynn

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 987d
  SEC Form 4 filed by Magovcevic-Liebisch Ivana

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 987d
  SEC Form 4 filed by Gray David L. F.

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 1089d
  Magovcevic-Liebisch Ivana bought $15,000 worth of shares (4,000 units at $3.75), increasing direct ownership by 2% to 207,687 units (SEC Form 4)

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 1194d
  SEC Form 4 filed by Silber Christopher

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 1194d
  SEC Form 3 filed by new insider Silber Christopher

  3 - Vigil Neuroscience, Inc. (0001827087) (Issuer)
• 1253d
  SEC Form 4 filed by Bruhn Suzanne Louise

  4 - Vigil Neuroscience, Inc. (0001827087) (Issuer)